恆宇集團(02448.HK):持牌法團A前兩月已參與兩單聯交所主板IPO包銷
格隆匯 3 月 2日丨恆宇集團(02448.HK)公佈,除持牌法團之客户資產(包括現金及股票)及在管資產於2021年2月28日合共約為23.4億港元,較2020年9月30日(即恆宇金控訂立持牌法團購買協議之日)增加約16.3倍之外。持牌法團A於2021年1月1日至2月28日已參與兩單聯交所主板IPO包銷,佔同期聯交所主板IPO包銷新股總數目約8.0%。
儘管2020年環球市場波動,香港交易所的一級市場領先全球IPO集資榜,共有154家公司在香港交易所上市,集資金額達3,975億港元,是2020年以來最高。集團將致力把握金融市場發展機遇,積極開拓金融服務業務以使符合集團及股東之整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.